The SocietyMore than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS communityBecome an ERS member
The PELICAN (Prematurity’s Effects on the Lungs in Children and Adults Network) Clinical Research Collaboration was launched by the European Respiratory Society (ERS) in 2020. Although enhanced perinatal care has markedly improved survival outcomes for all preterm infants, there is clear evidence of poorer lung health outcomes in this population. PELICAN has the overarching objective to harmonise cross-sectional and longitudinal datasets globally, to describe the impact of preterm birth on lung health trajectories over its life course, and to determine which neonatal and lifetime exposures contribute to the progression of lung disease in this vulnerable population.
The PELICAN Executive Scientific committee is composed of the CRC chairs, clinician researchers, experts in translational research, young investigators and patient representatives.
If you are interested in more information about PELICAN or would like to join the network, please contact email@example.com.